{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T22:57:32Z","timestamp":1773701852946,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,3,28]],"date-time":"2019-03-28T00:00:00Z","timestamp":1553731200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100009664","name":"Sociedad Espa\u00f1ola de Cardiolog\u00eda","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009664","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Cardiovasc Drugs"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1007\/s40256-019-00343-7","type":"journal-article","created":{"date-parts":[[2019,3,28]],"date-time":"2019-03-28T05:48:57Z","timestamp":1553752137000},"page":"487-495","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Renin\u2013Angiotensin System Blockade and Risk of Heart Failure After Myocardial Infarction Based on Left Ventricular Ejection Fraction: A Retrospective Cohort Study"],"prefix":"10.1007","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6549-4994","authenticated-orcid":false,"given":"Mar\u00eda","family":"Cesp\u00f3n-Fern\u00e1ndez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Raposeiras-Roub\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emad","family":"Abu-Assi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Manzano-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro","family":"Flores-Blanco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Barreiro-Pardal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"Casti\u00f1eira-Busto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel","family":"Mu\u00f1oz-Pousa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"L\u00f3pez-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Berenice","family":"Caneiro-Queija","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"Cobas-Paz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saleta","family":"Fern\u00e1ndez-Barbeira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pablo","family":"Dom\u00ednguez-Erquicia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis Manuel","family":"Dom\u00ednguez-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1ngel","family":"L\u00f3pez-Cuenca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miriam","family":"G\u00f3mez-Molina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Antonio","family":"Baz-Alonso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Calvo-Iglesias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariano","family":"Vald\u00e9s-Ch\u00e1varri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9s","family":"\u00cd\u00f1iguez-Romo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,3,28]]},"reference":[{"issue":"6","key":"343_CR1","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1161\/CIRCRESAHA.113.300268","volume":"113","author":"VL Roger","year":"2013","unstructured":"Roger VL. Epidemiology of heart failure. Circ Res. 2013;113(6):646\u201359.","journal-title":"Circ Res"},{"issue":"6","key":"343_CR2","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1177\/106002809302700617","volume":"27","author":"C Beckwith","year":"1993","unstructured":"Beckwith C, Munger MA. Effect of angiotensin-converting enzyme inhibitors on ventricular remodeling and survival following myocardial infarction. Ann Pharmacother. 1993;27(6):755\u201366.","journal-title":"Ann Pharmacother."},{"issue":"4","key":"343_CR3","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1161\/01.CIR.81.4.1161","volume":"81","author":"MA Pfeffer","year":"1990","unstructured":"Pfeffer MA, Braunwald E. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation. 1990;81(4):1161\u201372.","journal-title":"Circulation."},{"issue":"8951","key":"343_CR4","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/S0140-6736(95)90865-X","volume":"345","author":"ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group","year":"1995","unstructured":"ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group. A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. Lancet (Lond Engl). 1995;345(8951):669\u201385.","journal-title":"Lancet (Lond Engl)."},{"issue":"8906","key":"343_CR5","first-page":"1115","volume":"343","author":"GISSI-3: Gruppo Italiano per lo Studio della Sopravvivenza nell\u2019infarto Miocardico","year":"1994","unstructured":"GISSI-3: Gruppo Italiano per lo Studio della Sopravvivenza nell\u2019infarto Miocardico. Effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Lancet (Lond Engl). 1994;343(8906):1115\u201322.","journal-title":"Lancet (Lond Engl)."},{"issue":"10","key":"343_CR6","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1056\/NEJM199209033271001","volume":"327","author":"MA Pfeffer","year":"1992","unstructured":"Pfeffer MA, Braunwald E, Moye LA, Basta L, Brown EJ Jr, Cuddy TE, The SAVE Investigators, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. N Engl J Med. 1992;327(10):669\u201377.","journal-title":"N Engl J Med"},{"issue":"25","key":"343_CR7","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1056\/NEJM199512213332503","volume":"333","author":"L Kober","year":"1995","unstructured":"Kober L, Torp-Pedersen C, Carlsen JE, Bagger H, Eliasen P, Lyngborg K, Trandolapril Cardiac Evaluation (TRACE) Study Group, et al. A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med. 1995;333(25):1670\u20136.","journal-title":"N Engl J Med"},{"issue":"1","key":"343_CR8","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/eurheartj\/18.1.41","volume":"18","author":"JG Cleland","year":"1997","unstructured":"Cleland JG, Erhardt L, Murray G, Hall AS, Ball SG. Effect of ramipril on morbidity and mode of death among survivors of acute myocardial infarction with clinical evidence of heart failure. A report from the AIRE Study Investigators. Eur Heart J. 1997;18(1):41\u201351.","journal-title":"Eur Heart J."},{"issue":"9386","key":"343_CR9","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/S0140-6736(03)14284-5","volume":"362","author":"CB Granger","year":"2003","unstructured":"Granger CB, McMurray JJ, Yusuf S, Held P, Michelson EL, Olofsson B, et al. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial. Lancet (Lond Engl). 2003;362(9386):772\u20136.","journal-title":"Lancet (Lond Engl)."},{"issue":"5","key":"343_CR10","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1161\/hc3001.093502","volume":"104","author":"GR Dagenais","year":"2001","unstructured":"Dagenais GR, Yusuf S, Bourassa MG, Yi Q, Bosch J, Lonn EM, et al. Effects of ramipril on coronary events in high-risk persons: results of the Heart Outcomes Prevention Evaluation Study. Circulation. 2001;104(5):522\u20136.","journal-title":"Circulation"},{"issue":"5","key":"343_CR11","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1056\/NEJM199108013250501","volume":"325","author":"S Yusuf","year":"1991","unstructured":"Yusuf S, Pitt B, Davis CE, Hood WB, Cohn JN. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med. 1991;325(5):293\u2013302.","journal-title":"N Engl J Med."},{"issue":"3","key":"343_CR12","doi-asserted-by":"publisher","first-page":"445.e7","DOI":"10.1016\/j.ahj.2006.12.005","volume":"153","author":"C Borghi","year":"2007","unstructured":"Borghi C, Ambrosioni E. Effects of zofenopril on myocardial ischemia in post-myocardial infarction patients with preserved left ventricular function: the Survival of Myocardial Infarction Long-term Evaluation (SMILE)-ISCHEMIA study. Am Heart J. 2007;153(3):445.e7\u201314.","journal-title":"Am Heart J"},{"issue":"7","key":"343_CR13","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1001\/archinte.166.7.787","volume":"166","author":"N Danchin","year":"2006","unstructured":"Danchin N, Cucherat M, Thuillez C, Durand E, Kadri Z, Steg PG. Angiotensin-converting enzyme inhibitors in patients with coronary artery disease and absence of heart failure or left ventricular systolic dysfunction: an overview of long-term randomized controlled trials. Arch Intern Med. 2006;166(7):787\u201396.","journal-title":"Arch Intern Med"},{"issue":"1","key":"343_CR14","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1161\/CIRCULATIONAHA.106.685073","volume":"117","author":"JL Rouleau","year":"2008","unstructured":"Rouleau JL, Warnica WJ, Baillot R, Block PJ, Chocron S, Johnstone D, et al. Effects of angiotensin-converting enzyme inhibition in low-risk patients early after coronary artery bypass surgery. Circulation. 2008;117(1):24\u201331.","journal-title":"Circulation"},{"issue":"8875","key":"343_CR15","first-page":"821","volume":"342","author":"The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators","year":"1993","unstructured":"The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet (Lond Engl). 1993;342(8875):821\u20138.","journal-title":"Lancet (Lond Engl)."},{"issue":"3","key":"343_CR16","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1093\/eurheartj\/ehv320","volume":"37","author":"M Roffi","year":"2016","unstructured":"Roffi M, Patrono C, Collet JP, Mueller C, Valgimigli M, Andreotti F, et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). Eur Heart J. 2016;37(3):267\u2013315.","journal-title":"Eur Heart J"},{"issue":"2","key":"343_CR17","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","volume":"39","author":"B Ibanez","year":"2018","unstructured":"Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018;39(2):119\u201377.","journal-title":"Eur Heart J"},{"issue":"24","key":"343_CR18","doi-asserted-by":"publisher","first-page":"e139","DOI":"10.1016\/j.jacc.2014.09.017","volume":"64","author":"EA Amsterdam","year":"2014","unstructured":"Amsterdam EA, Wenger NK, Brindis RG, Casey DE Jr, Ganiats TG, Holmes DR Jr, et al. 2014 AHA\/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology\/American Heart Association Task Force on practice guidelines. J Am Coll Cardiol. 2014;64(24):e139\u2013228.","journal-title":"J Am Coll Cardiol"},{"issue":"16","key":"343_CR19","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1161\/CIR.0b013e31826e1058","volume":"126","author":"K Thygesen","year":"2012","unstructured":"Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, et al. Third universal definition of myocardial infarction. Circulation. 2012;126(16):2020\u201335.","journal-title":"Circulation"},{"issue":"6","key":"343_CR20","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1001\/archinte.166.6.659","volume":"166","author":"R Ferrari","year":"2006","unstructured":"Ferrari R. Effects of angiotensin-converting enzyme inhibition with perindopril on left ventricular remodeling and clinical outcome: results of the randomized Perindopril and Remodeling in Elderly with Acute Myocardial Infarction (PREAMI) Study. Arch Intern Med. 2006;166(6):659\u201366.","journal-title":"Arch Intern Med."},{"issue":"4","key":"343_CR21","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/S0735-1097(99)00634-8","volume":"35","author":"L Kjoller-Hansen","year":"2000","unstructured":"Kjoller-Hansen L, Steffensen R, Grande P. The angiotensin-converting enzyme inhibition post revascularization study (APRES). J Am Coll Cardiol. 2000;35(4):881\u20138.","journal-title":"J Am Coll Cardiol."},{"issue":"9215","key":"343_CR22","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1016\/S0140-6736(00)02212-1","volume":"355","author":"MD Flather","year":"2000","unstructured":"Flather MD, Yusuf S, Kober L, Pfeffer M, Hall A, Murray G, ACE-Inhibitor Myocardial Infarction Collaborative Group, et al. Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. Lancet (Lond Engl). 2000;355(9215):1575\u201381.","journal-title":"Lancet (Lond Engl)"},{"issue":"10","key":"343_CR23","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1056\/NEJM199209033271003","volume":"327","author":"S Yusuf","year":"1992","unstructured":"Yusuf S, Pitt B, Davis CE, Hood WB Jr, Cohn JN. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med. 1992;327(10):685\u201391.","journal-title":"N Engl J Med."},{"issue":"22","key":"343_CR24","doi-asserted-by":"publisher","first-page":"2721","DOI":"10.1016\/j.jacc.2017.04.017","volume":"69","author":"B Ibanez","year":"2017","unstructured":"Ibanez B, Raposeiras-Roubin S, Garcia-Ruiz JM. The swing of beta-blockers: time for a system reboot. J Am Coll Cardiol. 2017;69(22):2721\u201340.","journal-title":"J Am Coll Cardiol."},{"issue":"3","key":"343_CR25","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.ahj.2004.04.004","volume":"148","author":"L Kjoller-Hansen","year":"2004","unstructured":"Kjoller-Hansen L, Steffensen R, Grande P. Extended follow-up of patients randomly assigned in the Angiotensin-converting enzyme inhibition Post-Revascularization Study (APRES). Am Heart J. 2004;148(3):475\u201380.","journal-title":"Am Heart J."},{"issue":"7","key":"343_CR26","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.jchf.2017.04.007","volume":"5","author":"J Tromp","year":"2017","unstructured":"Tromp J, Khan MAF, Mentz RJ, O\u2019Connor CM, Metra M, Dittrich HC, et al. Biomarker profiles of acute heart failure patients with a mid-range ejection fraction. JACC Heart failure. 2017;5(7):507\u201317.","journal-title":"JACC Heart failure."},{"issue":"16","key":"343_CR27","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1161\/CIRCULATIONAHA.105.587519","volume":"113","author":"L Heerebeek van","year":"2006","unstructured":"van Heerebeek L, Borbely A, Niessen HW, Bronzwaer JG, van der Velden J, Stienen GJ, et al. Myocardial structure and function differ in systolic and diastolic heart failure. Circulation. 2006;113(16):1966\u201373.","journal-title":"Circulation"},{"issue":"10","key":"343_CR28","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1093\/eurjhf\/hfr079","volume":"13","author":"P Collier","year":"2011","unstructured":"Collier P, Watson CJ, Voon V, Phelan D, Jan A, Mak G, et al. Can emerging biomarkers of myocardial remodelling identify asymptomatic hypertensive patients at risk for diastolic dysfunction and diastolic heart failure? Eur J Heart Fail. 2011;13(10):1087\u201395.","journal-title":"Eur J Heart Fail"},{"issue":"4","key":"343_CR29","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jacc.2013.02.092","volume":"62","author":"WJ Paulus","year":"2013","unstructured":"Paulus WJ, Tschope C. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. J Am Coll Cardiol. 2013;62(4):263\u201371.","journal-title":"J Am Coll Cardiol"},{"key":"343_CR30","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.ijcard.2017.08.030","volume":"249","author":"SY Choi","year":"2017","unstructured":"Choi SY, Choi BG, Rha SW, Byun JK, Shim MS, Li H, et al. Angiotensin-converting enzyme inhibitors versus angiotensin II receptor blockers in acute ST-segment elevation myocardial infarction patients with diabetes mellitus undergoing percutaneous coronary intervention. Int J Cardiol. 2017;249:48\u201354.","journal-title":"Int J Cardiol"}],"container-title":["American Journal of Cardiovascular Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40256-019-00343-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40256-019-00343-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40256-019-00343-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,27]],"date-time":"2020-03-27T00:27:39Z","timestamp":1585268859000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40256-019-00343-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,28]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["343"],"URL":"https:\/\/doi.org\/10.1007\/s40256-019-00343-7","relation":{},"ISSN":["1175-3277","1179-187X"],"issn-type":[{"value":"1175-3277","type":"print"},{"value":"1179-187X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,28]]},"assertion":[{"value":"28 March 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"This study was supported by a clinical research grant from the Spanish Society of Cardiology (Sociedad Espa\u00f1ola de Cardiolog\u00eda [SEC]).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Mar\u00eda Cesp\u00f3n-Fern\u00e1ndez, Sergio Raposeiras-Roub\u00edn, Emad Abu-Assi, Sergio Manzano-Fern\u00e1ndez, Pedro Flores-Blanco, Cristina Barreiro-Pardal, Mar\u00eda Casti\u00f1eira-Busto, Isabel Mu\u00f1oz-Pousa, Elena L\u00f3pez-Rodr\u00edguez, Berenice Caneiro-Queija, Rafael Cobas-Paz, Saleta Fern\u00e1ndez-Barbeira, Pablo Dom\u00ednguez-Erquicia, Luis Manuel Dom\u00ednguez-Rodr\u00edguez, \u00c1ngel L\u00f3pez-Cuenca, Miriam G\u00f3mez-Molina, Jos\u00e9 Antonio Baz-Alonso, Francisco Calvo-Iglesias, Mariano Vald\u00e9s-Ch\u00e1varri, and Andr\u00e9s \u00cd\u00f1iguez-Romo have no potential conflicts of interest that might be relevant to the contents of this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The study was conducted in accordance with the principles of the Declaration of Helsinki and was approved by the local ethics committee.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}